Patent · US Active

Piperazine amide derivatives

US8288541B2 · kind B2 · utility

0Cited by

4References

22Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Henrietta Dehmlow · Weil am Rhein, DE
Bernd Kuhn · Sursee, CH
Ulrike Obst Sander · Sursee, CH
Stephan Roever · Inzlingen, DE
Tanja Schulz-Gasch · Ziefen, CH
Matthew Wright · Basel, CH
Rene Wyler · Zürich, CH

Key dates

Filing date	Aug 6, 2008
Grant date	Oct 16, 2012
Priority date	—
Expiry date	Jun 23, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is concerned with novel piperazine amide derivatives of formula (I)wherein R1 to R11, W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.